文献速递预防保健、筛查与疫苗儿童保健妇女保健

韩国青少年女孩人乳头瘤病毒疫苗接种与严重不良事件关联的全国队列研究

Association between human papillomavirus vaccination and serious adverse events in South Korean adolescent girls: nationwide cohort study.
PubMed 文献 · BMJ · 2021-01-29

该研究利用韩国免疫登记系统与国民健康信息数据库链接数据,纳入2017年接种的44万余名11-14岁女孩,评估HPV疫苗接种与33种严重不良事件的关联。队列分析未发现除偏头痛外的严重不良事件风险增加,自身对照风险区间分析未证实偏头痛关联。结论认为未见HPV疫苗与严重不良事件关联的证据。

要点

  • 全国性队列中HPV疫苗接种与33种严重不良事件总体无显著关联。
  • 队列分析仅偏头痛风险轻度增加,但自身对照分析未重复该结果。
  • 偏头痛的不一致发现需结合病理生理与人群特征谨慎解读。

核心结论

  • 在逾50万剂HPV疫苗接种的全国队列中,队列分析与自身对照风险区间分析均未发现HPV疫苗与严重不良事件关联的证据。
  • 偏头痛在队列分析中显示风险增加,但自身对照分析未证实,应谨慎解读。

研究设计与样本

  • 全国性队列研究,链接韩国免疫登记信息系统与国民健康信息数据库,时间范围为2017年1月至2019年12月。
  • 主要分析为队列设计,次要分析为自身对照风险区间设计,风险期均为接种后一年。
  • 主要分析采用泊松回归估计发病率与调整率比,次要分析采用条件逻辑回归估计调整相对风险。

主要发现

  • 33种预设严重不良事件中,队列分析未发现HPV疫苗接种相关关联。
  • 桥本甲状腺炎发病率每10万人年52.7 vs 36.3(接种组 vs 未接种组),调整率比1.24(95%CI 0.78-1.94)。
  • 类风湿关节炎发病率每10万人年168.1 vs 145.4,调整率比0.99(95%CI 0.79-1.25)。
  • 偏头痛发病率每10万人年1235.0 vs 920.9,调整率比1.11(95%CI 1.02-1.22)。
  • 自身对照风险区间分析未发现HPV疫苗接种与严重不良事件关联,偏头痛调整相对风险0.67(95%CI 0.58-0.78)。

临床怎么用

  • 全科医生可依据该研究向青少年女孩及家长说明HPV疫苗与严重不良事件无关联的全国性证据。
  • 对接种后主诉偏头痛者,可参考自身对照分析结果,避免将其直接归因于HPV疫苗。

局限性

  • 偏头痛结果在两种分析中不一致,需结合其病理生理与目标人群谨慎解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the association between human papillomavirus (HPV) vaccination and serious adverse events in adolescent girls in South Korea. DESIGN: Cohort study. SETTING: A large linked database created by linking the Korea Immunization Registry Information System and the National Health Information Database, between January 2017 and December 2019. PARTICIPANTS: 441 399 girls aged 11-14 years who had been vaccinated in 2017: 382 020 had been vaccinated against HPV and 59 379 had not been vaccinated against HPV. MAIN OUTCOME MEASURES: Outcomes were 33 serious adverse events, including endocrine, gastrointestinal, cardiovascular, musculoskeletal, haematological, dermatological, and neurological diseases. A cohort design was used for the primary analysis and a self-controlled risk interval design for the secondary analysis; both analyses used a risk period of one year after HPV vaccination for each outcome. Incidence rate and adjusted rate ratios were estimated using Poisson regression in the primary analysis, comparing the HPV vaccinated group with the HPV unvaccinated group, and adjusted relative risks were estimated using conditional logistic regression in the secondary analysis. RESULTS: Among the 33 predefined serious adverse events, no associations were found with HPV vaccination in the cohort analysis, including Hashimoto's thyroiditis (incidence rate per 100 000 person years: 52.7 v 36.3 for the vaccinated and unvaccinated groups; adjusted rate ratio 1.24, 95% confidence interval 0.78 to 1.94) and rheumatoid arthritis (incidence rate per 100 000 person years: 168.1 v 145.4 for the vaccinated and unvaccinated groups; 0.99, 0.79 to 1.25), with the exception of an increased risk observed for migraine (incidence rate per 100 000 person years: 1235.0 v 920.9 for the vaccinated and unvaccinated groups; 1.11, 1.02 to 1.22). Secondary analysis using self-controlled risk intervals confirmed no associations between HPV vaccination and serious adverse events, including migraine (adjusted relative risk 0.67, 95% confidence interval 0.58 to 0.78). Results were robust to varying follow-up periods and for vaccine subtypes. CONCLUSIONS: In this nationwide cohort study, with more than 500 000 doses of HPV vaccines, no evidence was found to support an association between HPV vaccination and serious adverse events using both cohort analysis and self-controlled risk interval analysis. Inconsistent findings for migraine should be interpreted with caution considering its pathophysiology and the population of interest.

来源:BMJ,查看原文。版权归原作者所有。

引用

  1. Yoon D, Lee JH, Lee H, et al. Association between human papillomavirus vaccination and serious adverse events in South Korean adolescent girls: nationwide cohort study. BMJ. 2021. PMID: 33514507. doi:10.1136/bmj.m4931

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。